{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:01:19Z","timestamp":1784653279041,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,21]]},"DOI":"10.7759\/cureus.113104","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:02:26Z","timestamp":1784649746000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Utility of Serum CA 19-9 Level in Colorectal Carcinoma Patients With Normal Serum Carcinoembryonic Antigen Levels: Correlation With Clinicopathological Features and Survival Outcomes"],"prefix":"10.7759","author":[{"given":"Avisikta","family":"Mallick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkaprovo","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, et al.. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020, 70:145-64. 10.3322\/caac.21601","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2014.1756","article-title":"Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010","volume":"150","author":"Bailey CE","year":"2015","unstructured":"Bailey CE, Hu CY, You YN, et al.. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015, 150:17-22. 10.1001\/jamasurg.2014.1756","journal-title":"JAMA Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla P","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019, 14:89-103. 10.5114\/pg.2018.81072","journal-title":"Prz Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3393\/ac.2019.11.13","article-title":"A review of the role of carcinoembryonic antigen in clinical practice","volume":"35","author":"Hall C","year":"2019","unstructured":"Hall C, Clarke L, Pal A, Buchwald P, Eglinton T, Wakeman C, Frizelle F. A review of the role of carcinoembryonic antigen in clinical practice. Ann Coloproctol. 2019, 35:294-305. 10.3393\/ac.2019.11.13","journal-title":"Ann Coloproctol"},{"key":"ref6","article-title":"Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma","volume":"14","author":"Diez M","year":"1994","unstructured":"Diez M, Cerd\u00e1n FJ, Poll\u00e1n M, et al.. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma. Anticancer Res. 1994, 14:2819-25.","journal-title":"Anticancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.7260","article-title":"Study on correlation between serum CA 19-9 and colorectal carcinoma with normal CEA","volume":"20","author":"Avisikta Mallick","year":"2022","unstructured":"Avisikta Mallick, Arkaprovo Roy. Study on correlation between serum CA 19-9 and colorectal carcinoma with normal CEA. J Natl Compr Canc Netw. 2022, 20:7260. 10.6004\/jnccn.2021.7260","journal-title":"J Natl Compr Canc Netw"},{"key":"ref8","article-title":"A study of factors influencing plasma CEA levels in an unselected population","volume":"1","author":"Herbeth B","year":"1980","unstructured":"Herbeth B, Bagrel A. A study of factors influencing plasma CEA levels in an unselected population. Oncodev Biol Med. 1980, 1:191-8.","journal-title":"Oncodev Biol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s G","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, et al.. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020, 31:1291-305. 10.1016\/j.annonc.2020.06.022","journal-title":"Ann Oncol"},{"key":"ref10","unstructured":"CA 19-9. Reference Range, Interpretation, Collection and Background. (2025). Accessed: March 1, 2026: https:\/\/emedicine.medscape.com\/article\/2087513-overview."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-1-66","article-title":"Carcinoembryonic antigen","volume":"104","author":"Fletcher RH","year":"1986","unstructured":"Fletcher RH. Carcinoembryonic antigen. Ann Intern Med. 1986, 104:66-73. 10.7326\/0003-4819-104-1-66","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1984.25","article-title":"Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases","volume":"49","author":"Kuusela P","year":"1984","unstructured":"Kuusela P, Jalanko H, Roberts P, Sipponen P, Mecklin JP, Pitk\u00e4nen R, M\u00e4kel\u00e4 O. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer. 1984, 49:135-9. 10.1038\/bjc.1984.25","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2152\/jmi.59.280","article-title":"High serum levels of both carcinoembryonic antigen and carbohydrate antigen 19-9 in a patient with sigmoid colon cancer without metastasis","volume":"59","author":"Nakatani H","year":"2012","unstructured":"Nakatani H, Kumon T, Kumon M, et al.. High serum levels of both carcinoembryonic antigen and carbohydrate antigen 19-9 in a patient with sigmoid colon cancer without metastasis. J Med Invest. 2012, 59:280-3. 10.2152\/jmi.59.280","journal-title":"J Med Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2013.67.397-401","article-title":"Cancer antigens (CEA and CA 19-9) as markers of advanced stage of colorectal carcinoma","volume":"67","author":"Vukobrat-Bijedic Z","year":"2013","unstructured":"Vukobrat-Bijedic Z, Husic-Selimovic A, Sofic A, Bijedic N, Bjelogrlic I, Gogov B, Mehmedovic A. Cancer antigens (CEA and CA 19-9) as markers of advanced stage of colorectal carcinoma. Med Arch. 2013, 67:397-401. 10.5455\/medarh.2013.67.397-401","journal-title":"Med Arch"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7150\/jca.31375","article-title":"High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy","volume":"10","author":"Zhou W","year":"2019","unstructured":"Zhou W, Yang F, Peng J, et al.. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy. J Cancer. 2019, 10:3810-8. 10.7150\/jca.31375","journal-title":"J Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2020.74.346-349","article-title":"The importance of determining preoperative serum concentration of carbohydrate antigen 19-9 and carcinoembryonic antigen in assessing the progression of colorectal cancer","volume":"74","author":"Halilovic E","year":"2020","unstructured":"Halilovic E, Rasic I, Sofic A, Mujic A, Rovcanin A, Hodzic E, Kulovic E. The importance of determining preoperative serum concentration of carbohydrate antigen 19-9 and carcinoembryonic antigen in assessing the progression of colorectal cancer. Med Arch. 2020, 74:346-9. 10.5455\/medarh.2020.74.346-349","journal-title":"Med Arch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/504564-clinical-utility-of-serum-ca-19-9-level-in-colorectal-carcinoma-patients-with-normal-serum-carcinoembryonic-antigen-levels-correlation-with-clinicopathological-features-and-survival-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:02:27Z","timestamp":1784649747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/504564-clinical-utility-of-serum-ca-19-9-level-in-colorectal-carcinoma-patients-with-normal-serum-carcinoembryonic-antigen-levels-correlation-with-clinicopathological-features-and-survival-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.113104","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}